1. Use of Low-Molecular-Weight Heparin and Peak anti-Xa Monitoring In Severe SARS-CoV-2 Disease: A Brief Report. (December 2021) Authors: Toor, Rebecca; Zamora, Francis J.; Fatteh, Naaz; Drexler, Nathan; Lozada, Jose Journal: Hospital pharmacy Issue: Volume 56:Number 6(2021) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗